uncxman
I have already explained to you that I am a long term investor in DNAP. When I first bought in sometime ago, I was impressed with what Frudakis had to say about what he was doing and intended to do. The personalized medicine technology was compelling and was the basic incentive for my investment.
However, over time, things just seemed to fall apart. Milestones for products and services were extended, never met, or cancelled altogether. What seemed to be a huge commercial market for predictive diagnostics has now dwindled to bare survival hawking low paying ancestry and forensics services. The company is experiencing huge annual losses and has decidedly gone downhill to its lowest pps ever since the Gabriel and wife management team took over. The future is indeed looking bleak, especially in anticipation of the r/s which will be the insult to injury for shareholders now holding shares just barely above subpenny.
These and many other negative points about the company and its management have given me serious concern about my investment. Perhaps I am not alone in this. Others on this board have also echoed my sentiments, although less candidly.
It seems you and others are invested in some successful stock other than DNAP, given the extreme differences in our respective opinions. This is the DNAP board is it not?
Am I able to say something positive about my investment? Yes, if and when the company and its management gives me some good reason to do so.
In the meantime, you, Gcbr and others may continue to violently lash out against for what I have to say, disparage me personally, and threaten me with various forms of public and private humiliation. I sympathize with how you all feel and will not prevail upon the board monitors to stifle your right to free speech.
JMHO
News 
Market Data 
Discover 
AI
